A recent cohort study involving 200 IBD patients identified visceral adiposity, rather than BMI, as a predictive risk factor for a shorter time to IBD flare, particularly for CD patients (90)
However, the severity of these side effects can vary among different GLP-1 medications
For healthy adults, Lemme Debloat is formulated for daily use
A: Animal studies show a link to thyroid tumors, but human evidence is unclear
Low GI TEAEs rates were observed with the most common being nausea (11.9% at 10 mg, 22.7% at 25 mg, 20.0% at 50 mg), diarrhea (4.8% at 10 mg, 20.5% at 25 mg, and 5% at 50 mg), and vomiting (2.4% at 10 mg, 11.4% at 25 mg, and 7.5% at 50 mg), generally consistent with the results of the Phase 1 trial of ribupatide oral conducted by Hengrui in China